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Abstract
Background: Patients with congenital diaphragmatic hernia (CDH) have a high residual morbidity rate. We
compared self-reported health-related quality of life (HRQoL) between patients with CDH and healthy children.
Methods: Forty-five patients with CDH who were born from January 1, 1990, through February 15, 2015, were
matched to healthy, age-matched control participants at a 1:2 ratio. The health records of the study participants were
reviewed to determine comorbid conditions, and HRQoL was assessed by both the participants and their parents with
the Pediatric Quality of Life Inventory (PedsQL). The HRQoL scores of the patients with CDH and the control
participants were compared by using analysis of variance to adjust for age group and sex. Among patients with CDH,
analysis of variance was used to compare HRQoL scores across groups defined according to their characteristics at
initial hospitalization, postdischarge events, and comorbid conditions.
Results: Compared with control participants, patients with CDH had lower mean PedsQL scores, as reported by the
parent and child, for the physical and psychosocial domains (P < 0.001). Risk factors associated with lower parent-
reported HRQoL included bronchopulmonary dysplasia, longer initial hospitalization, severe cognitive impairment, and
orthopedic symptoms; among patients with CDH, low HRQoL was associated with chronic respiratory issues.
Conclusion: Patients with CDH had lower HRQoL compared with healthy participants. Parent-reported HRQoL tended
to be higher than child-reported HRQoL. Results were also inconsistent for the risk factors associated with HRQoL
obtained by using child- and parent-reported scores. Therefore, when interpreting HRQoL in CDH survivors, a proxy
report should not be considered a substitute for a child’s self-report.
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Background
Assessment of chronically ill children and adolescents
with quality of life (QoL) instruments provides subjective
information about well-being in various domains of daily
life. Better understanding of health-related QoL (HRQoL)
of these patients may enable health practitioners to better
understand disease-specific symptoms, their association
with psychosocial functioning, and the development in the
daily life of children [1, 2]; this may ultimately help clinical
decision-making and parent counseling [3–5]. Bochdalek
congenital diaphragmatic hernia (CDH) is a rare develop-
mental defect of the diaphragm that causes the abdominal
viscera to herniate into the chest. Patients with CDH have
high morbidity and mortality rates [6, 7]. CDH manifests
when the diaphragm fails to close during development,
and the abdominal contents migrate into the chest
through this defect; pulmonary hypoplasia results because
there is limited room for the lungs to grow. These patients
often have pulmonary hypertension, asthma, gastrointes-
tinal reflux disease, feeding disorders, developmental delays,
and other comorbid conditions that may persist into adult-
hood [8–15]. This poor health status can substantially affect
QoL. Few studies have described HRQoL in patients with
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CDH [14, 16–19]. One study reported that 6- to 16-year-
old patients with CDH have lower HRQoL than similarly
aged healthy children [14]. Michel et al. [18] reported con-
siderably lower HRQoL scores for patients with CDH who
were 2.6 to 13.8 years old than for age- and sex-matched
control participants. In a cross-sectional study that in-
cluded patients born from 1969 through 1996, Poley et al.
[19] found that these differences in HRQoL between pa-
tients with CDH and healthy control patients decreased
with age. However, given the cross-sectional nature of that
study, the enrolled patients were born when the primary
treatment of CDH was considerably different than current
treatment; therefore, differences among age groups could
be due to survival bias or changes in treatment modalities.
This rare patient population is most commonly examined
using cross-sectional studies, and contemporary cohorts
consisting of patients with CDH born after the introduc-
tion of new therapeutic modalities (eg, protective ventila-
tion, extracorporeal membrane oxygenation [20–22]) are
needed.
Our institution is a tertiary referral center in Croatia
for patients with CDH. Our institutional registry of pa-
tients with CDH provides the opportunity to study pa-
tients with CDH, and describe temporal effects of CDH
on physical and mental function [6–9, 23, 24]. The pri-
mary objective of the current cross-sectional study was
to compare HRQoL between patients with CDH and a
control group of similarly aged, healthy children. The
Pediatric Quality of Life Inventory (PedsQL) [25], a gen-
eric HRQoL questionnaire, is one of the most commonly
used instruments for the assessment of physical, mental,
and social domains in healthy persons and persons with
functional limitations [26, 27]. We hypothesized that
PedsQL scores would be significantly lower for CDH sur-
vivors compared to healthy controls. The secondary ob-
jective was to examine potential associations among CDH
characteristics at initial presentation (eg, severity of pres-
entation at birth), postdischarge events, and HRQoL
scores of patients with CDH. QoL is not only a measure
of health but also reflects health perceptions and expecta-
tions, which may be influenced by physical, psychological,
and socioeconomic characteristics. Because PedsQL al-
lows assessment of the child self-report and the parent-
proxy report, and because of the inherent subjectivity of
assessing QoL, our tertiary objective was to evaluate
cross-informant variance in HRQoL ratings between par-
ents and their children with CDH. We aimed to determine
whether the proxy report could be used as a substi-
tute for the child’s self-report for assessing QoL in
patients with CDH.
Methods
This study was approved by the Institutional Ethics Com-
mittee of University Hospital Centre in Zagreb, Croatia.
All procedures were conducted in accordance with the
ethical standards of the institutional or national research
committee, the 1964 Helsinki Declaration and its later
amendments, or comparable ethical standards. Written
informed consent was obtained from all participants or
their legal guardians.
Study design and participants
Patients with CDH
This cross-sectional, single-center study of patients with
Bochdalek CDH was conducted at University Hospital
Centre, which is the largest Croatian medical center for
neonatal care. All patients with CDH born from January 1,
1990, through February 1, 2015, were invited to partici-
pate, and their parents received a telephone call or letter
in which the study objectives were described. HRQoL
questionnaires were completed by the patients and their
parents from March 1, 2015, through September 30, 2015.
Control participants
Patients with CDH were matched with healthy control
participants at a 1:2 ratio. Control participants were re-
cruited during well-child visits or visits for acute and
minor illnesses. Inclusion criteria were similar age to the
patients with CDH and no known chronic medical ill-
ness. This approach to recruit control participants by ex-
cluding those with chronic conditions has been utilized
before [19]. Our control participants and their parents
completed the HRQoL questionnaires during the same
time frame as the patients with CDH. Except for sex and
age, no demographic information was collected about
the control participants.
Data collection and interviews
In accordance with the original PedsQL administration
guidelines, questionnaires were completed by the partici-
pants and their parents before the completion of other
health data forms or the child’s physical examination. Par-
ents or participants independently completed the ques-
tionnaires without consultation.
HRQoL evaluation
We obtained permission to use the PedsQL question-
naire (version 4.0) [25]. This instrument has been vali-
dated to evaluate healthy children and adolescents, as
well as patients with acute and chronic health conditions
[26, 27]. The PedsQL questionnaire provides a child self-
report (for children ≥5 years) and a parent-proxy report
(for children > 2 years). Therefore, for children younger
than 5 years, only their parents completed the age-
appropriate HRQoL forms. For infants 1 to 12 and
13 to 24 months old, we obtained parent-proxy reports
by using the PedsQL infant scales. Infant Scales, include
36 items for 1 to 12-month-old infants and 45 items for
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13 to 24-month-old children that assess 5 dimensions
(physical, emotional, social, and cognitive functioning
and physical symptoms). For 2 to 4-year-old children,
we used the PedsQL Parent Report for Toddlers, which
includes 21 items that assess 4 dimensions (physical,
emotional, social, and preschool functioning). For the
children ages 5 to 7, 8 to 12, and 13 to 18 years old, and
young adults older than 18 up to 25 years old (PedsQL
Young Adult Version) the self-report scales include 23
items, which differ slightly according to age group, that
assess 4 dimensions (physical, emotional, social, and
school functioning). Parents and older children (≥5 years)
self-administered PedsQL after receiving instructions.
However, for 5 to 7-year-old children, PedsQL was ad-
ministered by reading the instructions to them (each item
was read word-for-word) and providing a separate page
that showed 3 facial expressions (ie, pictorial representa-
tions) to help the child understand how to answer.
Children aged 8 years and older scored questions using a
5-point Likert scale (0 [never] to 4 [almost always]), and
5- to 7-year-old children used a 3-point Likert scale an-
chored to the pictorial representations.
Although the PedsQL questionnaire introduces various
items (ie, questions) for different ages, the forms, regard-
less of age group, are essentially identical and only differ
in the developmentally appropriate language that is used.
Each response receives a value of 0%, 25%, 50%, or 100%
(representing a range from “never” to “always”) [25]. The
sum of the items divided by the number of answered
items generates the mean score. All responses were tab-
ulated to generate an overall health score and physical
health summary score. A psychosocial health summary
score was calculated using the sum of the answered
items in the emotional, social, school, and cognitive (or
school) function domains; separate scores were also cal-
culated for each of these subdomains in accordance with
published recommendations [25].
Perinatal health information and childhood medical
history
After completion of PedsQL, all patients (or their parents)
were interviewed to obtain their medical and surgical
histories. This interview was conducted by a neonatologist
(K.B.). In addition, participant health records were
reviewed to determine their demographic, neonatal, and
postnatal characteristics and medical histories. The col-
lected perinatal variables were sex, gestational age, birth
weight, postnatal duration of mechanical ventilation, dur-
ation of hospitalization, history of bronchopulmonary dys-
plasia (BPD) (as defined by Jobe and Bancalari) [28], type
of CDH in regard to the liver position (“liver up” vs “liver
down,” describes whether liver was herniated [“up”] or not
[“down”] into the thoracic cavity), and congenital anomal-
ies. By using birth weight and Apgar score at 5 min, we
calculated probability of survival scores as proposed by
the Congenital Diaphragmatic Hernia Study Group
(Apgar score assesses 5 vital signs—appearance, pulse,
grimace, activity, respiration—at 1 and 5 min after birth,
with the final score ranging from 0–10) [29]. This score
assigns the probability of survival after birth, and neonates
are categorized as having low (0%–33%), intermediate
(34%–66%), or high (67%–100%) survival probability. Of
note, this score is the accepted tool for grading CDH se-
verity after birth. A recurrent respiratory infection (RRI)
was defined as at least 3 respiratory episodes per year (or
per fall-winter season) for at least 2 years and included
treatment for wheezing and breathlessness [30]. Gastro-
esophageal reflux disease was recorded when indicated in
the health records or when the patient received treatment.
Furthermore, patients with CDH and their parents were
interviewed to obtain information about current and
chronic clinical issues using an inventory that was partly
adopted from Michel et al. [18]. We considered 4 major
health categories: digestive, respiratory, neuropsycho-
logical, and orthopedic. Digestive issues included oral
aversion and chronic problems (eg, vomiting, reflux, con-
stipation, diarrhea, abdominal pain, history of gastrointes-
tinal surgery). Chronic respiratory issues included dyspnea
at rest, exertional dyspnea, nocturnal dyspnea, chest pain,
RRI, use of respiratory medications, and hospitalization
for respiratory illness. Neuropsychological issues included
cerebral palsy and major cognitive impairment (all pa-
tients were formally tested for neurocognitive function,
and the results were previously reported [9]). Orthopedic
issues included skeletal deformities or any orthopedic
treatment. Finally, patients and their parents were asked
about all hospital readmissions (following the initial
hospitalization for CDH treatment) and surgical history.
Data management
Parent- and child-reported HRQoL scores were compared
between patients with CDH and control participants. Ana-
lysis of variance was used to adjust for sex and PedsQL
questionnaire age group (infants: 1–12 months; infants:
13–24 months; toddlers: 2–4 years; young children: 5–
7 years; children: 8–12 years; teens: 13–18 years; and
young adults: 18–25 years). For these analyses, the age-
and sex-adjusted differences between groups (patients
with CDH vs control participants) are calculated using a
multivariate regression mode with differences between
groups (CDH vs control) presented for all scores using
model estimates along with the corresponding 95% CI.
Overall HRQoL scores were compared between parents
and children using the paired t test when both assessments
were available. To assess whether differences between
parent-proxy report and child self-report were dependent
on the age of the child, a repeated measure analysis of vari-
ance was performed with respondent (parent vs child), age
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group, and the respondent-by-age group interaction term
included as the explanatory variables. In addition, in ana-
lyses restricted to CDH survivors and their parents, the as-
sociation of HRQoL scores with CDH characteristics at
initial hospitalization, postdischarge events, and comorbid
conditions, was assessed using analysis of variance. Separate
analyses were performed for parent proxy reports, and child
self-reports. In order to create groups of sufficient size for
meaningful comparisons when analyzing age at testing, the
two infant groups (< 12 months, 13–24 months) were com-
bined, as were children 5 to 7 and 8 to 12 years of age, and
those 13 years of age and older. The analysis of child self-
reports include only those ≥5 years of age at the time of
testing since only parent reports were available for infants
and children < 5 years old. Multiple comparison adjust-
ments were not performed, and in all cases unadjusted
2-tailed P values are reported.
Results
Study population
A total of 98 neonates with CDH were treated at Univer-
sity Hospital Centre from 1990 through 2015, and 44 neo-
nates were known to have died at study recruitment
(Fig. 1). Of the remaining 54 patients, 45 agreed to partici-
pate, 3 declined, and 6 were lost to follow-up. Therefore,
in the current study, we examined self-reported HRQoL
in 45 patients with CDH and 90 control participants. Pa-
tients with CDH had a mean (SD) age of 8.2 (5.7) years,
and 29 patients (64%) were male. The number of CDH
patients included in each of the PedsQL version– specific
age groups is presented in the Fig. 1. The mean (SD) age
of the control participants was 8.4 (6.1) years, and 40 par-
ticipants (44%) were male.
Comorbid conditions in patients with CDH
Among patients with CDH, 39 had left-sided CDH
and 6 had right-sided CDH; 12 patients were pre-
natally diagnosed. Additional demographic, disease,
and immediate postnatal surgical characteristics of
these patients are shown in Table 1. The burden of
these residual comorbid conditions was substantial
(see the patient summary in the Appendix). Thirty-
three patients with CDH (73%) were readmitted to
the hospital at least 1 time (115 total readmissions)
following their initial hospital discharge. The most
common reason for subsequent hospitalization was
related to respiratory problems (62 readmissions, of
which the majority were for RRI), followed by digest-
ive problems (26 readmissions). The remaining 27
readmissions were for a variety of reasons.
At the time of HRQoL testing, 29 patients with CDH
(64%) reported recent respiratory issues, of which RRI was
the most common (25 patients [56%]). Of these 25 patients
with RRI, 9 (36%) had a history of BPD (6 patients had se-
vere to moderate BPD, and 3 patients had mild BPD).
Interestingly, 6 patients with BPD did not report a recent
RRI (all patients had mild BPD and were > 10 years).
Twenty-three patients (51%) had digestive issues. Con-
stipation was the most commonly reported problem (23
patients [51%]), followed by recurrent diarrhea and gastro-
esophageal reflux disease (each reported by 5 patients
[11%]). Orthopedic issues affected 6 patients (13%), in-
cluding 1 patient with pectus excavatum and restrictive
pulmonary disease and 1 patient with kyphoscoliosis that
required bracing therapy. Neurologic issues were identi-
fied in 7 patients with CDH (16%); all of these patients
had severe cognitive impairment (including 1 patient with
cerebral palsy).
Fig. 1 Exclusion and Enrollment of Patients With Bochdalek Congenital Diaphragmatic Hernia Treated at University Hospital Centre in Zagreb,
Croatia. Abbreviations: CDH, congenital diaphragmatic hernia; mo, months; y, years
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PedsQL scores of patients with CDH and control
participants
Table 2 shows the parent- and child-reported HRQoL
scores of the patients with CDH and control participants.
Patients with CDH had significantly lower HRQoL (as re-
ported by the parent-proxy report and patient self-report)
compared with control participants, as shown by the over-
all scores, physical health summary scores, and psycho-
social health summary scores (all P < 0.001) and the scores
on the emotional, social, and school subdomains (all P ≤
0.02). The only nonsignificant finding between control
participants and patients with CDH was the parent-
reported cognitive scores for 1- to 24-month-old children
(P = 0.69). In the analysis restricted to complete child and
parent pairs (ie, both completed HRQoL assessments [28
patients with CDH and 60 control participants]), the
child’s self-reported scores were significantly lower than
the parent-reported scores. The mean (SD) overall scores
were 75.0 (13.9) for patients with CDH and 80.6 (12.0) for
their parents (P = 0.046). The difference between parent
and child reports was not found to be dependent on the
child’s at testing (respondent-by-age interaction P = 0.769).
The mean (SD) overall scores were 85.4 (8.8) for control
participants and 88.8 (6.8) for their parents (P < 0.001), with
no evidence of an interaction between respondent and age
at testing (respondent-by-age interaction P = 0.533).
Tables 3 and 4 present the HRQoL scores of the patients
with CDH according to their characteristics at birth
(including CDH severity) and after their initial hospital
discharge. Among patients with CDH, these exploratory
analyses showed that parent-reported HRQoL was lower
when their children also had BPD, longer initial
hospitalization, severe neurologic issues (most commonly
severe cognitive impairment), or orthopedic symptoms; in
addition, parent-reported HRQoL differed by the child’s
age, and 5- to 12-year-old patients had the lowest HRQoL
(Table 3). Among patients with CDH, a recent history of
pulmonary symptoms was the only characteristic that was
negatively associated with HRQoL (Table 4).
Discussion
Many of our patients with CDH had substantial comor-
bid conditions (Appendix), and these comorbid condi-
tions may have affected HRQoL. Using PedsQL, we
found that the HRQoL of the patients with CDH, as
measured by the child self-reports and parent-proxy re-
ports, was considerably lower than that of the control
participants. For both parent-proxy reports and child
self-reports, the magnitude of QoL reduction was con-
sistent for the overall score and all relevant subscores.
The child self-reports showed significantly lower QoL
than the parent-proxy reports; therefore, when interpret-
ing QoL in CDH survivors, a proxy report should not be
considered a substitute for a child’s self-report. This
finding should be considered in situations when only
proxy HRQoL report is available for decision-making
[31]. In addition, discordance was found between pa-
tients with CDH and their parents in regard to specific
characteristics associated with low HRQoL. For example,
respiratory disease was the only characteristic markedly
associated with low HRQoL in the child self-reports, but
several characteristics—all descriptors of postnatal CDH
severity—were associated with lower HRQoL when re-
ported in the parent-proxy reports.
Parent-proxy and child self-reports of HRQoL and charac-
teristics associated with HRQoL
Because of the lower cognitive and language skills of young
children, PedsQL includes parent-proxy reports to obtain
information about children. The use of questionnaires with
child and parent versions has raised questions about the
level of agreement between children and their parents
about child functioning. Some investigators reported poor
parent-child agreement [32, 33], but others reported
Table 1 Demographic, Disease, and Surgical Characteristics of
Patients With CDH at Birth (n = 45)
Characteristic Value
Prenatal diagnosis, n (%) 12 (26.7)
Male sex, n (%) 29 (64.4)
Gestational age, mean (SD), weeks 38.7 (2)
Birth weight, mean (SD), kg 3.11 (0.53)
Apgar score at 5 min, mean (SD) 7.8 (2.2)
Probability of survival, n (%)
High (67%–100%) 31 (68.9)
Intermediate (34%–66%) 12 (26.7)
Low (0%–33%) 2 (4.4)
CDH side, n (%)a
Left 39 (86.7)
Right 6 (13.3)
Duration of hospitalization, median (IQR), days 28 (18–57)
Congenital anomalies, n (%) 25 (55.6)
Cardiovascularb 7 (15.6)
Renalc 4 (8.9)
Gastrointestinald 4 (8.9)
Skeletale 7 (15.6)
Otherf 3 (6.7)
CDH Congenital diaphragmatic hernia, IQR Interquartile range, SD Standard
deviation
a Seven patients with left-sided CDH were “liver up”; all 6 patients with right-
sided CDH were “liver up”
b Includes patent foramen ovale (n = 1), atrial septal defect II (n = 3), and
patent ductus arteriosus (n = 3)
c Includes hydronephrosis (n = 2), multicystic kidney (n = 1), and hypoplastic
kidney (n = 1)
d Includes accessory spleen (n = 2) and Meckel diverticulum (n = 2)
e Includes foot deformities (n = 3) and abnormal number of ribs (n = 4)
f Includes macroglossia (n = 1), neck fistula (n = 1), and preauricular tag (n = 1)
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moderate to high agreement [34, 35]. One study used both
child self-reports and parent-proxy reports to evaluate QoL
of patients with CDH [18], but to our knowledge our study
is the first to simultaneously obtain child self-reports and
parent-proxy reports by using a validated instrument and
to directly compare these sources. In our study, parent-
reported HRQoL was slightly but consistently higher than
child-reported HRQoL. When patient and disease charac-
teristics were tested for potential associations with HRQoL,
our findings were inconsistent between parent and child
assessments. The lack of agreement among individual vari-
ables associated with child- and parent-reported HRQoL
scores may be due to complex, interrelated, overlapping
disease characteristics; thus, identifying a single characteris-
tic that is consistently associated with low HRQoL is diffi-
cult. Patients with CDH may have complex comorbid
conditions that contribute to low HRQoL scores in diverse
ways when reported by a child versus a parent. In our
study, the characteristics that are descriptors of the severity
of the postnatal course were not associated with reduced
HRQoL scores in the child self-reports. Similarly, Koivusalo
et al. [17] observed lower than expected HRQoL in 25% of
patients with CDH, but no correlation between CDH
severity and HRQoL scores was reported. A single
variable—chronic respiratory problems, which are often
linked with multiple hospitalizations—was associated with
low child self-reported HRQoL in our study. In contrast,
longer initial hospitalization, postnatal BPD, severe cogni-
tive impairment, and chronic orthopedic problems were all
associated with lower HRQoL when reported by parents
but not children.
Discordant perceptions of HRQoL between child self-
reports and parent-proxy reports have been reported
[36, 37]. In many instances, when the parent and child
disagree, the evidence does not clearly show that parents
overestimated or underestimated HRQoL. Glaser et al.
[35] suggested that parents can appropriately report in-
formation about their child’s HRQoL, but others indi-
cated that parents tend to rate their child’s HRQoL
lower than their child [32, 33]. Davis et al. [31] suggested
that “discordance in HRQoL scores between parents and
children may be due to different reasoning and response
styles rather than item interpretation.” In a study by Sai-
gal et al. [38], parents were asked to rate the HRQoL of
their infants with extremely low birth weight, and, des-
pite the presence of substantial disease burden, average
HRQoL was high. In our study, the scores of the
parent-proxy reports were consistently higher than
the scores of the child self-reports. Investigations of
adult populations have shown that patients are more
reliable and consistent at scoring their own QoL than
their physicians [39, 40]; therefore, patient reports should
be the criterion standard when this information is used
for interventions and treatments. Another study assessed
Table 2 Parent- and Child-Reported PedsQL Scores of Patients With CDH and Control Participantsa
Participants With CDH Healthy Control Participants Estimated Difference (CDH–Control)b
Assessment n Mean Score (SD) n Mean Score (SD) Estimate 95% CI P Value
Parent report
Overall score 45 81.2 (14.8) 90 89.2 (6.4) −8.2 −11.7 to − 4.7 < 0.001
Physical health summary 45 82.2 (17.0) 90 90.5 (8.4) −8.3 −12.5 to −4.1 < 0.001
Psychosocial health summary 45 80.1 (15.4) 90 88.5 (6.9) −8.5 −12.2 to −4.7 < 0.001
Emotional 45 75.8 (15.2) 90 83.1 (11.0) −8.0 −12.5 to −3.5 < 0.001
Social 45 85.6 (19.5) 90 93.2 (8.8) −7.3 −11.9 to −2.8 0.002
School 37 79.3 (21.2) 74 91.0 (9.3) −11.5 −17.2 to −5.8 < 0.001
Cognitivec 8 90.6 (11.1) 16 92.8 (9.9) −1.8 −10.8 to 7.2 0.69
Child report
Overall score 28 75.0 (13.9) 60 85.4 (8.8) −10.7 −15.6 to − 5.9 < 0.001
Physical health summary 28 74.7 (16.5) 60 84.8 (11.6) −10.7 − 16.7 to −4.7 < 0.001
Psychosocial health summary 28 75.4 (14.6) 60 85.6 (8.9) −10.3 − 15.4 to −5.3 < 0.001
Emotional 28 69.6 (16.6) 60 79.8 (13.5) −10.8 −17.4 to −4.2 0.002
Social 28 82.7 (18.3) 60 89.9 (9.9) −6.9 −12.9 to − 1.0 0.02
School 28 73.2 (19.6) 60 86.8 (10.9) −13.9 −20.4 to −7.4 < 0.001
CDH Congenital diaphragmatic hernia, PedsQL Pediatric Quality of Life Inventory, SD Standard deviation
a Patients with CDH had a mean (SD) age of 8.2 (5.7) years and consisted of 29 males (64%) and 16 females (36%). Control participants had a mean (SD) age of 8.4
(6.1) years and consisted of 40 males (44%) and 50 females (56%)
b The difference between patients with CDH and control was estimated using multiple regression with group (CDH vs. control) as the explanatory variable of
interest and age group and sex included as adjustor variables
cOnly reported by the parents of 1- to 24-month-old infants. For this age group, the psychosocial health summary score is calculated as the sum of the
items divided by the number of items answered in the emotional, social, and cognitive functioning scales
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Table 3 Parent-Reported Quality of Life Scores of Patients With CDH Stratified by Characteristics at Birth, CDH Severity, and Major
Lifetime Comorbid Conditions
Characteristic Patients (n) Mean Overall
Score (SD)
P Value* Mean Physical
Score (SD)
P Value* Mean Psychosocial
Score (SD)
P Value*
Characteristics at birth
Sex 0.38 0.72 0.35
Male 29 82.7 (15.4) 82.9 (18.3) 81.7 (16.0)
Female 16 78.5 (13.5) 81.0 (14.9) 77.1 (14.5)
Probability of survival score 0.08 0.06 0.08
Low or intermediate 14 75.5 (18.1) 75.0 (20.1) 74.0 (18.4)
High 31 83.7 (12.5) 85.4 (14.7) 82.8 (13.3)
CDH type 0.81 0.94 0.62
Liver down 32 80.8 (13.4) 82.1 (15.7) 79.3 (14.3)
Liver up 13 82.1 (18.3) 82.5 (20.7) 81.9 (18.5)
BPD 0.003 0.01 0.007
Yes 15 72.2 (19.2) 73.3 (20.3) 71.5 (20.0)
No 30 85.7 (9.5) 86.7 (13.4) 84.4 (10.5)
Initial hospitalization, days 0.01 0.15 0.008
≤ 30 24 86.9 (8.3) 86.1 (14.1) 86.4 (8.6)
31–60 11 77.4 (10.3) 81.4 (16.3) 75.0 (10.1)
≥ 61 10 71.3 (23.7) 73.7 (22.3) 70.4 (24.9)
Mechanical ventilation, days 0.08 0.07 0.12
≤ 7 22 86.6 (8.8) 88.5 (12.3) 85.4 (9.4)
8–21 13 78.4 (13.0) 78.7 (15.6) 76.8 (14.1)
≥ 22 9 76.6 (20.0) 75.2 (23.3) 77.1 (19.6)
Postdischarge events
Hospitalizations, n 0.08 0.03 0.13
0 12 86.8 (10.0) 88.3 (9.5) 85.8 (12.1)
1–2 17 83.1 (10.2) 86.3 (15.1) 81.5 (10.0)
≥ 3 16 74.9 (19.6) 73.3 (20.2) 74.3 (20.5)
Characteristics at testing
Age 0.03 0.045 0.03
< 24 months 8 83.8 (9.2) 83.9 (7.8) 83.7 (11.3)
2–4 years 7 93.2 (5.8) 97.3 (4.9) 90.7 (7.3)
5–12 years 18 74.5 (17.2) 76.4 (19.0) 72.5 (18.2)
≥ 13 years 12 82.4 (13.1) 81.0 (18.5) 82.8 (12.2)
Digestive issues 0.06 0.046 0.07
Yes 23 77.2 (17.2) 77.3 (19.3) 76.0 (17.9)
No 22 85.4 (10.5) 87.3 (12.7) 84.3 (11.3)
Respiratory issues 0.40 0.13 0.62
Yes 29 79.8 (15.7) 79.3 (17.8) 79.2 (16.3)
No 16 83.7 (13.0) 87.4 (14.7) 81.6 (14.1)
Orthopedic issues 0.01 0.007 0.04
Yes 6 67.0 (21.9) 65.1 (23.4) 68.1 (22.1)
No 39 83.4 (12.3) 84.8 (14.5) 81.9 (13.6)
Bojanić et al. Health and Quality of Life Outcomes  (2018) 16:50 Page 7 of 12
QoL in children with chronic pain and suggested that, al-
though merit should be given to parent-proxy reports, the
child’s own perspective should be directly solicited when-
ever possible [2].
Association between age of patients with CDH and
HRQoL scores
Because numerous comorbid conditions associated with
CDH in early childhood resolve with age and chronic
health conditions may affect a person’s subjective percep-
tion of HRQoL, self-reported HRQoL scores may be
affected by the child’s age [19, 41]. Poley et al. [19]
conducted a cross-sectional study and observed poor
HRQoL in young patients with CDH but normal HRQoL
in children older than 16 years. Poley et al. concluded that,
despite considerable early morbidity, the ultimate progno-
sis of CDH as measured with HRQoL is favorable. In con-
trast, using PedsQL questionnaires, Sheikh et al. [41]
reported good HRQoL scores in patients with CDH, even
in younger patients (mean age, 5.5 years), regardless of
CDH severity at birth. This discordance between studies
may be due to the associations between CDH and various
comorbid conditions (eg, cardiac, pulmonary), which have
variable degrees of severity and potential to improve over
time. In addition, given the cross-sectional nature of these
studies, the association between QoL and age is difficult
to interpret, because at the time they were surveyed for
the present study, older patients had received treatments
when contemporary therapeutic modalities were unavail-
able, resulting in survival of healthier children; therefore,
these older CHD participants may have less-severe re-
sidual disease. For all of these reasons, comparison of out-
comes in cross-sectional studies is associated with
complexities related to unaccounted confounders.
In our study, HRQoL of the patients with CDH differed
with the age of the child. Five- to 12-year-old children had
considerably lower parent-reported HRQoL. A plausible,
albeit speculative, explanation for this finding is that these
children are more engaged in competitive school activities,
and therefore parents may notice that their child does not
perform at the same level as their peers. Whether this ra-
tionale would also apply to child self-reports cannot be
assessed because children under the age of 5 years did not
complete a questionnaire. However, it appears that a simi-
lar perception of low health status exists for 5- to 12-year-
old children and their parents because both groups
reported low scores (Tables 3 and 4).
Limitations
This study is limited by its retrospective design. Evalu-
ation of a wide range of ages with a cross-sectional study
precludes the ability to precisely assess whether HRQoL
changes with time. Given the rarity of CDH, the statis-
tical power to assess differences across age groups is
limited by the small number of patients in some age
groups. In addition, a parent’s assessment of their child’s
HRQoL may be influenced by unaccounted elements
(eg, life experience, expectations for their child, physical
and psychological health, socioeconomic status, sex, race
and ethnicity, family relationships, and parental stress
related to their child’s disease) [1, 2]. Furthermore, adapta-
tion to disease may affect a child’s perception of HRQoL,
but we cannot account for this possibility. In order to en-
sure that our control group was not skewed by individuals
with chronic comorbidities, when selecting control partici-
pants, we excluded participants with chronic medical ill-
ness. This approach may have overestimated the HRQoL of
our control participants compared with the general
population.
Conclusions
Across a wide range of ages, patients with CDH had
lower self-reported HRQoL scores in the physical and
psychosocial domains compared with similarly aged,
healthy control participants. However, no patient charac-
teristics, comorbid conditions, or symptoms were consist-
ently associated with worse HRQoL in the child or parent
assessments. Although we were unable to determine why
children reported lower QoL scores, we believe that clin-
ical interventions based on QoL information should pri-
marily consider the child’s report, and that the child’s own
perspective of well-being should be a criterion standard
for implementation of corrective measures. Proxy re-
sponses for evaluation of QoL in CDH survivors should
be used only when patient responses are not available.
Table 3 Parent-Reported Quality of Life Scores of Patients With CDH Stratified by Characteristics at Birth, CDH Severity, and Major
Lifetime Comorbid Conditions (Continued)
Characteristic Patients (n) Mean Overall
Score (SD)
P Value* Mean Physical
Score (SD)
P Value* Mean Psychosocial
Score (SD)
P Value*
Neurologic issues < 0.001 0.05 < 0.001
Yesa 7 64.7 (22.6) 70.8 (24.3) 60.4 (21.1)
No 38 84.2 (10.7) 84.3 (14.8) 83.7 (11.1)
BPD Bronchopulmonary dysplasia, CDH Congenital diaphragmatic hernia, SD Standard deviation. All scores are expressed as mean (SD)
aAll 7 patients with CDH and neurologic issues had severe cognitive impairment; 1 patient also had cerebral palsy
*The given health-related quality of life score was compared across groups using analysis of variance (ANOVA)
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Table 4 Child-Reported Quality of Life Scores of Patients With CDH Stratified by Characteristics at Birth, CDH Severity, and Major
Lifetime Comorbid Conditions
Characteristic Patients (n) Mean Overall
Score (SD)
P Value* Mean Physical
Score (SD)
P Value* Mean Psychosocial
Score (SD)
P Value*
Characteristics at birth
Sex 0.56 0.16 0.95
Male 15 76.4 (14.3) 78.8 (17.4) 75.2 (14.2)
Female 13 73.3 (13.7) 70.0 (14.5) 75.6 (15.6)
Probability of survival score 0.71 0.89 0.63
Low or intermediate 8 73.4 (14.7) 75.4 (14.1) 73.2 (16.8)
High 20 75.6 (13.9) 74.4 (17.6) 76.3 (13.9)
CDH type 0.81 0.42 0.93
Liver down 22 75.3 (13.6) 76.0 (15.8) 75.3 (14.2)
Liver up 6 73.7 (16.2) 69.8 (19.4) 75.8 (17.3)
BPD 0.56 0.76 0.47
Yes 9 72.7 (12.0) 73.3 (15.6) 72.4 (11.9)
No 19 76.0 (14.9) 75.3 (17.2) 76.8 (15.8)
Initial hospitalization, days 0.48 0.47 0.40
≤ 30 15 76.3 (13.0) 73.8 (15.7) 78.1 (14.0)
31–60 10 75.9 (15.7) 78.8 (18.3) 74.3 (15.1)
≥ 61 3 65.6 (12.2) 65.6 (14.3) 65.6 (16.2)
Mechanical ventilation, days 0.99 0.93 0.88
≤ 7 13 75.3 (16.1) 73.3 (15.7) 76.9 (17.8)
8–21 10 74.3 (13.3) 75.6 (19.0) 73.7 (12.1)
≥ 22 5 75.4 (11.2) 76.3 (16.3) 75.0 (11.7)
Postdischarge events
Hospitalizations, n 0.75 0.24 0.39
0 6 78.3 (8.5) 70.3 (14.4) 82.7 (9.8)
1–2 11 75.3 (18.1) 81.3 (17.3) 72.7 (18.4)
≥ 3 11 72.8 (12.0) 70.5 (15.8) 74.1 (11.9)
Characteristics at testing
Age, years 0.76 0.38 0.99
5–12 16 74.3 (13.8) 72.3 (16.6) 75.4 (14.4)
≥ 13 12 75.9 (14.6) 77.9 (16.5) 75.4 (15.4)
Digestive issues 0.22 0.51 0.18
Yes 17 72.3 (15.5) 73.0 (16.9) 72.4 (16.3)
No 11 79.1 (10.2) 77.3 (16.2) 80.0 (10.4)
Respiratory issues 0.02 0.01 0.10
Yes 16 69.9 (14.7) 68.0 (16.4) 71.4 (16.2)
No 12 81.7 (9.1) 83.6 (11.9) 80.7 (10.3)
Orthopedic issues 0.76 0.97 0.67
Yes 5 76.7 (10.5) 74.4 (17.9) 78.0 (8.0)
No 23 74.6 (14.7) 74.7 (16.6) 74.8 (15.7)
Neurologic issues 0.13 0.27 0.11
Yes 3 63.4 (15.8) 64.6 (15.7) 62.8 (20.0)
No 25 76.4 (13.3) 75.9 (16.4) 76.9 (13.5)
BPD Bronchopulmonary dysplasia, CHD Congenital diaphragmatic hernia, SD Standard deviation. All scores are expressed as mean (SD)
aThe given health-related quality of life score was compared across groups using analysis of variance (ANOVA)
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Appendix
Table 5 Chronic Health-Related Conditions in Patients with CDH
Patient QoL Score Age, Sex Hospital
Readmissionsa
(N)
Major Health Issues or Conditionsb, c
Child Report Parent Report
1 NA 90.3 6 mo, M 1 RRI
2 NA 78.6 7 mo, M 1 DOR, DOE, RRI
3 NA 91.4 10 mo, M 0 Surgery (clubfoot), RRI
4 NA 95.0 3 mo, M 0 None
5 NA 80.6 20 mo, M 1 Oral aversion, malnourished,
DOE, RRI, inguinal hernia repair
6 NA 86.0 22 mo, M 2 RRI, DOE
7 NA 82.2 23 mo, M 6 RRI, atopic dermatitis, inguinal
hernia repair, orchidopexy
8 NA 66.3 16 mo, F 0 Multicystic kidney, IQ < 70
9 NA 82.1 4 y, F 7 Galactosemia, cataract
surgery, RRI, IQ < 70
10 NA 95.2 3 y, M 1 Surgery (SBO, CDH reherniation)
11 NA 94 3 y, M 0 None
12 NA 100 4 y, M 5 DOE, DOR, nocturnal dyspnea, RRI
13 NA 96.4 4 y, F 0 RRI
14 NA 95.2 4 y, M 0 RRI
15 NA 89.3 4 y, M 2 RRI
16 NA 39.1 5 y, M 4 IQ < 70, hyperactivity disorder,
DOE, RRI, NPF-up
17 63.0 89.1 5 y, F 0 RRI
18 73.9 84.9 5 y, F 1 RRI
19 81.8 85.9 5 y, F 0 RRI, DOE
20 78.3 82.6 5 y, F 0 None
21 45.7 83.7 5 y, M 2 RRI, asthma, IQ < 70
22 NA 35.8 7 y, M 4 IQ < 70, cerebral palsy, DOE, RRI,
NPF-up, difficulty walking,
surgeries (CDH reherniation, SBO)
23 76.1 53.3 7 y, F 15 Severe pectus excavatum, RRI,
DOE, DOR, oral aversion, GERD,
IQ < 70, NPF-up, pain ambulating,
surgery (SBO)
24 62.0 72.8 8 y, F 4 DOE, RRI, hydronephrosis, surgeries
(CDH reherniation, neck fistula,
preauricular tag)
25 85.9 84.8 8 y, M 6 DOE, RRI, surgery
(equinovarus, orchidopexy)
26 94.6 81.5 9 y, M 13 NPF-up, oral aversion, malnourished,
GERD, DOE, RRI, surgeries
(adenoidectomy, abdominal
patch removal)
27 81.5 82.6 10 y, F 1 Surgery (SBO)
28 52.2 54.8 11 y, F 4 NPF-up, seizures, GERD, DOE,
hearing and visual impairment,
surgery (SBO)
29 75.0 89.1 11 y, M 3 Oral aversion, pain ambulating,
selective mutism, NPF-up
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Table 5 Chronic Health-Related Conditions in Patients with CDH (Continued)
Patient QoL Score Age, Sex Hospital
Readmissionsa
(N)
Major Health Issues or Conditionsb, c
Child Report Parent Report
30 66.3 67.3 12 y, M 1 Adenoidectomy
31 89.1 86.9 12 y, F 0 Congenital blindness, attending
special school, NPF-up
32 71.7 80.0 12 y, M 5 DOE, RRI, surgeries (inguinal hernia
repair, orchidopexy)
33 91.3 88.0 13 y, M 2 RRI, orchidopexy
34 68.5 92.4 13 y, M 5 NPF-up, IQ < 70, learning difficulties,
vomiting, RRI, surgeries
(SBO, closure ductus Botalli)
35 95.7 98.9 13 y, M 2 Surgeries (orchidopexy, hydrocele repair)
36 79.4 58.69 14 y, F 1 Brace therapy (scoliosis), pain ambulating
37 79.4 58.7 14 y, M 0 Primary night enuresis, NPF-up
38 83.7 100 14 y, M 3 Atopic asthma
39 45.7 78.3 15 y, F 2 DOE, adenoidectomy
40 64.1 70.7 15 y, M 1 GERD, chest pain
41 67.4 73.9 15 y, M 3 CVI due to AV malformation, residual
hemiparesis, loss of visual field, NPF-up
42 64.1 77.2 17 y, M 4 Bronchiectasis, GERD, DOE, RRI
43 91.3 92.4 18 y, F 1 Pain ambulating
44 93.5 88.0 20 y, M 2 None
45 78.3 90.2 20 y, F 0 Hashimoto thyroiditis, DOE
AV Arteriovenous, CDH Congenital diaphragmatic hernia, CVI Cerebrovascular insult, DOE Dyspnea on exertion, DOR Dyspnea on rest, F Female, GERD
Gastroesophageal reflux disease, IQ Intelligence quotient, M Male, N Number, NA Not applicable, NPF-up Neurologic and/or psychiatric follow-up, QoL Quality of
life, RRI Recurrent respiratory infection, SBO Small-bowel obstruction
aReadmissions account for all hospitalizations after discharge from initial treatment; b Information was obtained from medical records and by interview; c Includes
some major morbidities or surgical procedures during initial hospitalization for treatment of CDH and all comorbidities after initial discharge
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